1
John R Cardinal, Scott M Herbig, Richard W Korsmeyer, Jeelin Lo, Kelly L Smith, Avinash G Thombre: Asymmetric membranes in delivery devices. Pfizer, Peter C Richardson, Gregg C Benson, A Dean Olson, December 16, 1997: US05698220 (70 worldwide citation)

A device for controlled release of an active substance through one or more asymmetric membranes by diffusion and/or osmotic pumping.


2
Leah E Appel, William J Curatolo, Scott M Herbig, James A S Nightingale, Avinash G Thombre: Controlled release by extrusion of solid amorphous dispersions of drugs. Pfizer, Peter C Richardson, Gregg C Benson, James T Jones, March 16, 2004: US06706283 (70 worldwide citation)

Controlled release dosage forms for low solubility drugs are disclosed wherein an amorphous solid dispersion of the drug is coated with a non-dissolving and non-eroding coating that controls the influx of water to the core so as to cause extrusion of a portion of the core, as well as a method of tre ...


3
John R Cardinal, Scott M Herbig, Richard W Korsmeyer, Jeelin Lo, Kelly L Smith, Avinash G Thombre: Use of asymmetric membranes in delivery devices. Pfizer, Peter C Richardson, Gregg C Benson, A Dean Olson, March 18, 1997: US05612059 (54 worldwide citation)

A device for controlled release of an active substance through one or more asymmetric membranes by diffusion and/or osmotic pumping.


4
Scott M Herbig, Eric J Miller: Osmotic-delivery devices having vapor-permeable coatings. S C Johnson & Son, August 25, 1998: US05798119 (34 worldwide citation)

An osmotic device that, following the imbibition water vapor, provides for the controlled release of a beneficial agent to a non-aqueous environment. The device comprises a hydrophilic formulation and a beneficial agent, surrounded by a wall. The wall is formed at least in part of a semipermeable hy ...


5
Timothy A Hagen, Julian B Lo, Avinash G Thombre, Scott M Herbig, Leah Elizabeth Appel, Marshall David Crew, Dwayne Thomas Friesen, David Keith Lyon, Scott Baldwin McCray, James Blair West: Azithromycin dosage forms with reduced side effects. Pfizer, Gregg C Benson, B Timothy Creagan, Lance Y Liu, January 10, 2006: US06984403 (23 worldwide citation)

The present invention is related to an oral dosage form comprising an effective amount of an alkalizing agent and an azithromycin multiparticulate wherein said multiparticulate comprises azithromycin, a glyceride which comprises glyceryl monobehenate, glyceryl dibehenate, glyceryl tribehenate, or a ...


6
Scott M Herbig, Kelly L Smith, Paul Van Eikeren, James B West: Supported liquid membrane delivery devices. Pfizer, Peter C Richardson, Gregg C Benson, A Dean Olson, February 18, 1997: US05603953 (23 worldwide citation)

Supported liquid membrane delivery devices that release a beneficial agent to an aqueous environment following exposure to an environmental trigger. A microporous hydrophobic support membrane at least partially surrounds a beneficial agent- containing hydrophilic formulation. A hydrophobic liquid is ...


7
Edward L Cussler, Scott M Herbig, Kelly L Smith, Paul van Eikeren: Osmotic devices having vapor-permeable coatings. Pfizer, Peter C Richardson, Gregg C Benson, A Dean Olson, October 27, 1998: US05827538 (21 worldwide citation)

An osmotic device that, following the imbibement of water vapor, provides for the controlled release of a beneficial agent to an aqueous environment. The device comprises a hydrophilic formulation including a beneficial agent, and if needed, an osmagent, surrounded by a wall. The wall is formed at l ...


8
Scott M Herbig, Kelly L Smith: PH-triggered osmotic bursting delivery devices. Pfizer, Peter C Richardson, Gregg C Benson, A Dean Olson, March 11, 1997: US05609590 (19 worldwide citation)

An osmotic bursting device for dispensing a beneficial agent to an aqueous environment. The device comprises a beneficial agent and osmagent surrounded at least in part by a semipermeable membrane. Alternatively the beneficial agent may also function as the osmagent. The semipermeable membrane is pe ...


9
Leah E Appel, William J Curatolo, Scott M Herbig, James A S Nightingale, Avinash G Thombre: Controlled release by extrusion of solid amorphous dispersions of drugs. Bend Research, Chernoff Vilhauer McClung & Stenzel, June 23, 2009: US07550158 (15 worldwide citation)

Controlled release dosage forms for low solubility drugs are disclosed wherein an amorphous solid dispersion of the drug is coated with a non-dissolving and non-eroding coating that controls the influx of water to the core so as to cause extrusion of a portion of the core, as well as a method of tre ...


10
Paul van Eikeren, Daniel J Brose, Scott M Herbig: Adsorbents for the removal of volatile substances from aqueous systems. Bend Research, Chernoff Vilhauer McClung & Stenzel, February 25, 1992: US05091080 (13 worldwide citation)

Semipermeable membrane-enclosed solid core adsorbent devices for the selective removal of volatile chemical species from an aqueous environment are disclosed.